Amgen Stock Surges Past 52-Week High Amid Strong Growth Drivers
Amgen's stock price has reached a new 52-week high of $440.51 on August 21, 2026, before closing at $439.33.
The stock has gained 16.8% over the past month due to strong second-quarter results and increased guidance.
Amgen's key growth drivers include Repatha, Evenity, Tezspire, and biosimilar products, which are expected to drive top-line growth in future quarters.